SCHEMBL2937547

SCHEMBL2937547

O=[N+]([O-])C1=CCC=C1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18568339 0.84 ALDH1A1 (0.31)
SCHEMBL4422198 0.78
SCHEMBL349091 0.76
SCHEMBL1846174 0.76
SCHEMBL12195354 0.73 GPR35 (0.31)
SCHEMBL11938776 0.69 POLB (0.32)
SCHEMBL378762 0.68
SCHEMBL11820953 0.67
SCHEMBL7701653 0.67 GSK3A (0.32)
SCHEMBL2227308 0.65

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240025882-A1 BENZAMIDES OF PYRAZOLYLAMINO- PYRIMIDINYL DERIVATIVES, AND COMPOSITIONS AND METHODS THEREOF LYNK PHARMACEUTICALS CO. LTD. (CN) 2024-01-25 US disclosed
WO-2019188499-A1 METHOD FOR PRODUCING α-OLEFIN/(METH)ACRYLIC ACID ESTER COPOLYMER 日本ポリエチレン株式会社 2019-10-03 WO disclosed
US-8841276-B2 Fulvene and fulvalene analogs and their use in treating cancers EMORY UNIVERSITY (US) 2014-09-23 US disclosed
US-20130338208-A1 FULVENE AND FULVALENE ANALOGS AND THEIR USE IN TREATING CANCERS U.S. GOVERNMANET AS REPRESENTED BY UNITED STATES DEPARTMENT OF VETERANS AFFAIRS (US) 2013-12-19 US disclosed
WO-2013149185-A1 PROCESSES FOR PREPARING TUBULYSIN DERIVATIVES AND CONJUGATES THEREOF ENDOCYTE, INC. (US) 2013-10-03 WO disclosed
CN-101772344-A Fulvene and fulvalene analogs and their use in the treatment of cancer UNIV EMORY (US) 2010-07-07 CN disclosed
EP-2148666-A1 FULVENE AND FULVALENE ANALOGS AND THEIR USE IN TREATING CANCERS Emory University (US) 2010-02-03 EP disclosed
WO-2008137740-A1 FULVENE AND FULVALENE ANALOGS AND THEIR USE IN TREATING CANCERS EMORY UNIVERSITY (US) 2008-11-13 WO disclosed
US-20080275016-A1 For drug resistant cancers; antiinflammatory agents;degenerative or vascular diseases; blocking nitrogen oxide so growth of tumors is suppressed U.S. GOVERNMENT AS REPRESENTED BY THE DEPARTMENT OF VETERANS AFFAIRS, THE 2008-11-06 US disclosed